Product Information
Name:BCR-ABL-IN-6
Brand:Targetmol
Description:BCR-ABL-IN-6, an imatinib derivative, inhibits Bcr-AblWT (4.6 nM IC50) and T315I (277 nM), for chronic myeloid leukemia study.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:505.49
Formula:C27H22F3N5O2
Color/Form:Solid
Technical inquiry about: BCR-ABL-IN-6
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.